Vertex Pharmaceuticals Inc
VRTX
NASDAQ
Biotechnology
$505.75
USD
-10.69 (-2.07%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $135.24B
Volume 1.1M
Price Target
$442.00 – $595.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $595.00 and a min estimate of $442.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$518.50
-$55.3 vs prior
Implied Upside
+2.5%
-10.9% vs prior
Analyst Covering
2
-10 vs prior period
Consensus
Hold
Declined vs prior
Signal Quality
Consensus Freshness
14%
Many ratings are older - consensus may be less current
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Hold
1 Buy
1 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Whitney Ijem | Canaccord Genuity | Hold | Maintained | 1 week ago | Plus | Plus | Plus |
Carter Gould | Cantor Fitzgerald | Buy | Maintained | 1 week ago | Plus | Plus | Plus |
Frequently Asked Questions
